Controlled Release of Oxycodone 10 mg In Pre-Medication For The Post Operative Analgesia In Elective Laparoscopic Bilateral Inguinal Hernia And Elective Laparoscopic Cholecystectomy
Recruitment status was: Not yet recruiting
A Prospective Double Blind RCT: Controlled Release Oxycodone 10 mg On a 12 h Dosing Schedule Started With The Premedication ,Placebo Controlled Study,On Post Operative Analgesia Management in Laparoscopic Cholecystectomy and Laparoscopic Bilateral Inguinal Hernia (BIH).
CRO is indicated for the management of moderate to severe pain when a continuous,around the clock analgesic is needed for an extended period of time.Its safety and efficacy in the first 12-24 hours post operative has not been established.
|Elective Laproscopic Bilateral Inguinal Hernia Elective Laproscopic Cholecystectomy||Drug: Oxycodone 10 mg||Phase 4|
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
|Official Title:||Controlled Release of Oxycodone 10 mg In Pre-Medication For The Post Operative Analgesia In Elective Laparoscopic Bilateral Inguinal Hernia And Elective Laparoscopic Cholecystectomy : Prospective Double Blind, Randomized, Placebo-Controlled Study|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00480142
|Contact: Oscar Liphshitz, MDemail@example.com|
|Principal Investigator:||patricia grosman, MD||Israel: Kaplan Hospital, Clalit Health Service|
|Study Chair:||Eli Mavor, MD||Israel:Clalit Health Service|
|Study Director:||oscar liphshitz, MD||Isreal: Kaplan: Clalit Health Service|
|Study Director:||Bella Almog, R.N MA||Israel: Kaplan: Clalit Health Service|